scispace - formally typeset
W

William K. Gottschalk

Researcher at Duke University

Publications -  30
Citations -  1218

William K. Gottschalk is an academic researcher from Duke University. The author has contributed to research in topics: Genome-wide association study & Apolipoprotein E. The author has an hindex of 17, co-authored 28 publications receiving 1049 citations. Previous affiliations of William K. Gottschalk include University of Pennsylvania & University of Tennessee Health Science Center.

Papers
More filters
Journal ArticleDOI

Comprehensive messenger ribonucleic acid profiling reveals that peroxisome proliferator-activated receptor γ activation has coordinate effects on gene expression in multiple insulin-sensitive tissues

TL;DR: The effects of the potent, tyrosine-based PPARγ ligand GW1929 on serum glucose and lipid parameters and gene expression in Zucker diabetic fatty rats are characterized and a comprehensive and unbiased messenger RNA profiling technique is used to identify genes regulated either directly or indirectly by PParγ in epididymal white adipose tissue, interscapular brown adipose tissues, liver, and soleus skeletal muscle.
Journal ArticleDOI

Novel loci and pathways significantly associated with longevity

TL;DR: A genome-wide association study of Han Chinese with a sample size 2.7 times the largest previously published GWAS on centenarians suggests protective mechanisms including immunity and nutrient metabolism and their interactions with environmental stress play key roles in human longevity.
Journal ArticleDOI

The cis-regulatory effect of an Alzheimer’s disease-associated poly-T locus on expression of TOMM40 and apolipoprotein E genes

TL;DR: The genomic region spanning the Translocase of the Outer Mitochondrial Membrane 40‐kD (TOMM40) and Apolipoprotein E (APOE) genes, that has been associated with the risk and age of onset of late‐onset Alzheimer's disease (LOAD) is investigated to determine whether a highly polymorphic, intronic poly‐T within this region affects expression of the APOE and TOMM40 genes.
Journal ArticleDOI

The Broad Impact of TOM40 on Neurodegenerative Diseases in Aging.

TL;DR: The TOM40-mediated mitochondrial protein import mechanism is described, and the evidence linking TOM40 with Alzheimer's (AD) and Parkinson's (PD) diseases is discussed, and new targets for preventative and/or therapeutic treatments are discussed.
Journal ArticleDOI

Using genetics to enable studies on the prevention of Alzheimer's disease.

TL;DR: A composite genetic biomarker is presented to stratify disease risk so as to facilitate clinical studies in high‐risk populations and the rationale for the use of pioglitazone to delay the onset of AD in individuals at high risk is discussed.